Spotify Apple Youtube

Category: NAFLD Prevalence

All Podcast Categories
S4-26.3 - FibroScan and the Impact of Socioeconomic Factors on Liver Health

S4-26.3 – FibroScan and the Impact of Socioeconomic Factors on Liver Health

The podcast celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. This conversation offers observations around the new NICE guidance that supports FibroScan use in primary care settings. The group ventures on to discuss the effects of socioeconomic status on access to improved liver health.

June 12, 2023
S4-26.2 - the Rise of NAFLD/NASH in Adolescents

S4-26.2 – The Rise of NAFLD/NASH in Adolescents

The podcast celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. This conversation focuses on the increasing incidence of NAFLD/NASH among adolescents. The group explores ideas around why this is happening and what to do about it.

June 12, 2023
S4-25.5 - Wrap-Up on NICE Guidance for FibroScan

S4-25.5 – Wrap-Up on NICE Guidance for FibroScan

William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This final conversation addresses a closing question around the future of FibroScan and how NICE will have progressed on the issue over the next 18 months.

June 12, 2023
S4-25.4 - NICE Guidance for FibroScan: The Devil is in the Details

S4-25.4 – NICE Guidance for FibroScan: The Devil is in the Details

William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This conversation offers stimulating ideas around best ways to implement community screening.

June 12, 2023
S4-25.2 - NICE Guidance for FibroScan: Collecting Data Well and Wisely

S4-25.2 – NICE Guidance for FibroScan: Collecting Data Well and Wisely

William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This conversation speculates on the value and accuracy of FAST and other tests. The group considers the importance of collecting data and what impact the guidance and experience in the UK will have for onlooking systems.

June 12, 2023
S4-E25.1 - Meeting Vanessa Hebditch and the Role of the British Liver Trust in Fighting for FibroScan

S4-E25.1 – Meeting Vanessa Hebditch and the Role of the British Liver Trust in Fighting for FibroScan

William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This conversation focuses on the role of the British Liver Trust in this process and the importance of data collection for quality assurance.

June 12, 2023
S4-26 - Patient Advocate Focus on International #NASHDay 2023

S4-26 – Patient Advocate Focus on International #NASHDay 2023

The episode celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. Each speaks to what the day means to them and the group explores how the community is taking action to step up to a public health epidemic.

June 9, 2023
S4-25 - Exciting News! NICE Guidance Supports FibroScan Use Outside Secondary and Specialist Care in the UK

S4-25 – Exciting News! NICE Guidance Supports FibroScan Use Outside Secondary and Specialist Care in the UK

To kick off International #NASHDay 2023, Surfing NASH starts its ongoing coverage with an episode dedicated to a momentous and fitting announcement. William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK.

June 8, 2023
Stay In Touch
Apple Spotify Youtube

Sponsoring Partnerships

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.

Learn More